Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Study on the Construction and Implementation Effect of a Traditional Chinese Medicine-Based Mental-Physical Comorbidity Linked Health-Management System of "Hospital-Community-Family" for Breast Cancer Patients

In this study, the effect-implementation mixed research design was adopted. The patients were assigned to the intervention group and the control group at a ratio of 2 : 1 by the central stratified randomization method. The stratification factors were four phenotypes of psychosomatic symptoms ( anxiety and depression, sleep disorders, fatigue and mixed symptoms ). The intervention group was determined by the three-stage conversation model of doctor-patient joint decision-making, and the personalized acupuncture intervention program was determined. Combined with the patient 's own needs and service accessibility, the hospital intervention subgroup or the medical-social-home intervention subgroup scenario was determined. The control group was given routine nursing. Because the intervention requires informed interaction between doctors and patients, only outcome evaluators and data analysts are blinded. The intervention period was 8 weeks of treatment and 4 weeks of follow-up, a total of 12 weeks. Based on the evaluation of the effect of acupuncture intervention on the improvement of psychosomatic symptoms, the study was guided by the CFIR framework to evaluate the implementation of the hospital intervention subgroup and the medical-social-family intervention subgroup formed after the joint decision-making of doctors and patients, identify the implementation obstacles and promotion factors, and evaluate the implementation outcomes such as acceptability, feasibility, implementation loyalty and coverage.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Estimado)

216

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Tianjin, China
        • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  1. Female, aged 18-70 years

  2. Histologically or cytologically confirmed breast cancer (AJCC 8th Edition Stage 0-IV)

  3. At least one psychosomatic symptom meeting the following criteria:

    • Anxiety or depression: Hospital Anxiety and Depression Scale (HADS) anxiety or depression subscale ≥ 8
    • Sleep disorder: Pittsburgh Sleep Quality Index (PSQI) total score ≥ 8
    • Cancer-related fatigue: Brief Fatigue Inventory (BFI) total score ≥ 4
  4. Expected survival ≥ 1 year

  5. Alert, conscious, with basic communication ability, able to complete questionnaire assessments

  6. Signed informed consent by patient or legal guardian

Exclusion Criteria:

  1. Severe mental disorders (e.g., schizophrenia, bipolar disorder) or lack of civil capacity
  2. Unsuitable for auricular acupressure: local auricular skin damage/infection/allergy to Vaccaria seeds or tape
  3. Currently receiving other acupuncture/acupressure interventions, or unable to discontinue during the study period
  4. Unsuitable for acupuncture: bleeding tendency (e.g., coagulopathy, purpura), or local acupoint damage
  5. Severe cardiac, hepatic, or renal failure, or cachexia
  6. Pregnant or breastfeeding women

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Experimental: Intervention Group

Participants receive personalized acupuncture intervention (acupuncture and/or auricular acupressure) determined through the Shared Decision Making three-stage conversation model, on top of standard care. Patients choose either hospital-based or hospital-community-family intervention sub-group based on personal needs and service accessibility. Treatment duration: 8 weeks intervention + 4 weeks follow-up.

Sem intervenção: Control Group

Participants receive standard care only, including diet, exercise, emotional regulation guidance, and health education based on the Breast Cancer Psychosomatic Health Education Manual. No active acupuncture intervention for psychosomatic symptoms during the study period.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Functional Assessment of Cancer Therapy-Breast, FACT-B
Prazo: 8 weeks

Instruments for assessing Quality of Life (QoL) among breast cancer patients;Functional Assessment of Cancer Therapy-Breast (FACT-B Version 4.0) Uniform response options: 0 = Not at all, 1 = A little bit, 2 = Somewhat, 3 = Quite a bit, 4 = Very much Unified scoring rule for all subscales and total scores: Higher scores indicate better quality of life among breast cancer patients; lower scores reflect more severe physical, emotional, social and breast-specific distress.

8 weeks

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Hospital anxiety and depression scale,HADS
Prazo: 8 weeks

Hospital Anxiety and Depression Scale (HADS) Full Scoring Standard Specifications Subscale 1: Anxiety subscale (HADS-A) Number of items: 7 Minimum score: 0 Maximum score: 21 Interpretation: Higher scores mean more severe anxiety symptoms. Subscale 2: Depression subscale (HADS-D) Number of items: 7 Minimum score: 0 Maximum score: 21 Interpretation: Higher scores mean more severe depressive symptoms. HADS total score Composition: HADS-A score + HADS-D score Minimum score: 0 Maximum score: 42 Interpretation: Higher total scores indicate more severe combined anxiety and depression symptoms.

Supplementary Response Option Rule (Standard HADS 4-point Likert) All items adopt 4-point scoring from 0 to 3; higher single item scores stand for worse emotional conditions.

8 weeks
Pittsburgh sleep quality index,PSQI
Prazo: 8 weeks

Pittsburgh Sleep Quality Index (PSQI) Full Scoring Standard Description PSQI component subscores (7 sleep dimensions) Each component score range: 0-3 PSQI global total score Full name: Pittsburgh Sleep Quality Index Global Score Minimum score: 0 Maximum score: 21 Interpretation: Higher global scores represent worse overall sleep quality; lower scores indicate better sleep quality.

8 weeks
Brief Fatigue Inventory,BFI
Prazo: 8 weeks

Brief Fatigue Inventory (BFI) Full Scoring Standard Description Single item scoring range for each fatigue item: 0-10 BFI Global Fatigue Severity Score Full name: Brief Fatigue Inventory Global Fatigue Severity Score Minimum score: 0 Maximum score: 10 Interpretation: Higher scores indicate more severe fatigue; lower scores represent milder fatigue status.

Supplement The total global score is the average of all 9 items of the BFI. Each item uses a 0-10 numerical rating scale, where 0 = no fatigue at all and 10 = worst fatigue imaginable.

8 weeks
Brief Pain Inventory,BPI
Prazo: 8 weeks

Brief Pain Inventory (BPI) Full Scoring Standard Description Single item scoring range: Each pain-related item is scored on a 0-10 numeric rating scale (0 = no pain, 10 = worst pain imaginable) BPI Pain Severity Score Full name: Brief Pain Inventory Pain Severity Score Composition: Average score of 4 pain severity items (worst pain, least pain, average pain, pain right now) Minimum score: 0 Maximum score: 10 Interpretation: Higher scores mean greater pain severity BPI Pain Interference Score Full name: Brief Pain Inventory Pain Interference Score Composition: Average score of 7 pain interference items (interference with general activity, mood, walking ability, normal work, relations with others, sleep, enjoyment of life) Minimum score: 0 Maximum score: 10 Interpretation: Higher scores indicate more severe interference of pain on daily life

8 weeks

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Acceptability of the intervention
Prazo: 8 weeks

Acceptability of the intervention is assessed using a 4-item, 5-point Likert scale. Each item is scored from 1 to 5. The total score is calculated as the sum of the four item scores, ranging from 4 to 20. Higher scores indicate greater acceptability. A total score of ≥16 indicates good acceptability.

8 weeks
Feasibility of the intervention
Prazo: 8 weeks

Feasibility of the intervention is assessed using a 4-item, 5-point Likert scale. Each item is scored from 1 to 5. The total score is calculated as the sum of the four item scores, ranging from 4 to 20. Higher scores indicate greater feasibility. A total score of ≥16 indicates good feasibility.

8 weeks
Implementation Fidelity: Auricular Acupressure Treatment Adherence Rate
Prazo: 8 weeks

Auricular acupressure treatment adherence rate = (Number of auricular acupressure sessions actually completed / Number of required sessions) × 100%. An adherence rate of ≥80% indicates good adherence.

8 weeks
Implementation Fidelity: Self-Pressing Adherence Rate
Prazo: 8 weeks

Self-pressing adherence was assessed by recording the daily frequency of self-pressing in patient logs and verifying the records by asking participants during follow-up visits. An adherence rate of ≥90% indicates good adherence.

8 weeks
Coverage of the intervention
Prazo: 8 weeks

Coverage was defined as the proportion of eligible breast cancer patients with psychosomatic symptoms who participated in the study.

8 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

30 de outubro de 2026

Conclusão Primária (Estimado)

31 de dezembro de 2028

Conclusão do estudo (Estimado)

31 de dezembro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

18 de outubro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de novembro de 2026

Primeira postagem (Real)

17 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 25ZXWQSY00040

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .